News & Views
GSK issues swine flu vaccine update
Apr 01 2010
In an update regarding the virus, GSK said it is working closely with governments from around the world to offer bespoke programmes for dealing with the issue.
"Pandemics by their nature are unpredictable and we recognise that governments needs are changing," it explained.
Earlier this year, the pharmaceutical giant said it started delivering two doses of the vaccine, but found high immune responses after lab testing to one of the medicines.
According to the firm, it continues to collect data regarding clinical trial programmes in relation to H1N1 medications and recently amended an existing agreement with Japan to deliver 68 per cent of ordered units.
The World Health Organization note laboratory-confirmed testing has revealed over 200 countries are experiencing swine flu cases.
Digital Edition
LMUK 49.7 Nov 2024
November 2024
Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Handling - Clinical, Medical & Diagnostic Products News...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan